View in EDS

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.

Saved in:
Bibliographic Details
Title: Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.
Authors: Nataraj NB; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Noronha A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Lee JS; Cancer Data Science Lab, National Cancer Institute, NIH, Rockville, MD, USA., Ghosh S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Mohan Raju HR; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Sekar A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Zuckerman B; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Lindzen M; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Tarcitano E; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Srivastava S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Selitrennik M; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Livneh I; Technion Integrated Cancer Center (TICC) and the Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel., Drago-Garcia D; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Rueda O; Cancer Research UK Cambridge Institute, University of Cambridge and the Cambridge Cancer Centre, Department of Oncology, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge and the Cambridge Cancer Centre, Department of Oncology, Cambridge, UK., Lev S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Geiger T; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ciechanover A; Technion Integrated Cancer Center (TICC) and the Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel., Ulitsky I; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Seger R; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Ruppin E; Cancer Data Science Lab, National Cancer Institute, NIH, Rockville, MD, USA., Yarden Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. Electronic address: yosef.yarden@weizmann.ac.il.
Source: Cell reports [Cell Rep] 2022 Feb 22; Vol. 38 (8), pp. 110418.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35196484
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nataraj+NB%22">Nataraj NB</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Noronha+A%22">Noronha A</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Cancer Data Science Lab, National Cancer Institute, NIH, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ghosh+S%22">Ghosh S</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Mohan+Raju+HR%22">Mohan Raju HR</searchLink>; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Sekar+A%22">Sekar A</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Zuckerman+B%22">Zuckerman B</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Lindzen+M%22">Lindzen M</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Tarcitano+E%22">Tarcitano E</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Srivastava+S%22">Srivastava S</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Selitrennik+M%22">Selitrennik M</searchLink>; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Livneh+I%22">Livneh I</searchLink>; Technion Integrated Cancer Center (TICC) and the Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Drago-Garcia+D%22">Drago-Garcia D</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Rueda+O%22">Rueda O</searchLink>; Cancer Research UK Cambridge Institute, University of Cambridge and the Cambridge Cancer Centre, Department of Oncology, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Caldas+C%22">Caldas C</searchLink>; Cancer Research UK Cambridge Institute, University of Cambridge and the Cambridge Cancer Centre, Department of Oncology, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lev+S%22">Lev S</searchLink>; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Geiger+T%22">Geiger T</searchLink>; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Ciechanover+A%22">Ciechanover A</searchLink>; Technion Integrated Cancer Center (TICC) and the Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Ulitsky+I%22">Ulitsky I</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Seger+R%22">Seger R</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Ruppin+E%22">Ruppin E</searchLink>; Cancer Data Science Lab, National Cancer Institute, NIH, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yarden+Y%22">Yarden Y</searchLink>; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. Electronic address: yosef.yarden@weizmann.ac.il.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101573691%22">Cell reports</searchLink> [Cell Rep] 2022 Feb 22; Vol. 38 (8), pp. 110418.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101573691 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-1247 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35196484
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.celrep.2022.110418
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 110418
    Titles:
      – TitleFull: Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nataraj NB
      – PersonEntity:
          Name:
            NameFull: Noronha A
      – PersonEntity:
          Name:
            NameFull: Lee JS
      – PersonEntity:
          Name:
            NameFull: Ghosh S
      – PersonEntity:
          Name:
            NameFull: Mohan Raju HR
      – PersonEntity:
          Name:
            NameFull: Sekar A
      – PersonEntity:
          Name:
            NameFull: Zuckerman B
      – PersonEntity:
          Name:
            NameFull: Lindzen M
      – PersonEntity:
          Name:
            NameFull: Tarcitano E
      – PersonEntity:
          Name:
            NameFull: Srivastava S
      – PersonEntity:
          Name:
            NameFull: Selitrennik M
      – PersonEntity:
          Name:
            NameFull: Livneh I
      – PersonEntity:
          Name:
            NameFull: Drago-Garcia D
      – PersonEntity:
          Name:
            NameFull: Rueda O
      – PersonEntity:
          Name:
            NameFull: Caldas C
      – PersonEntity:
          Name:
            NameFull: Lev S
      – PersonEntity:
          Name:
            NameFull: Geiger T
      – PersonEntity:
          Name:
            NameFull: Ciechanover A
      – PersonEntity:
          Name:
            NameFull: Ulitsky I
      – PersonEntity:
          Name:
            NameFull: Seger R
      – PersonEntity:
          Name:
            NameFull: Ruppin E
      – PersonEntity:
          Name:
            NameFull: Yarden Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 02
              Text: 2022 Feb 22
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2211-1247
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Cell reports
              Type: main
ResultId 1